Table 1 Characteristics (sex, type of sphere, number of lesions, their volumes and strategy of treatment) of patients included in this study
From: Dosimetric impact of 3D motion-compensated SPECT reconstruction for SIRT planning
Patient number | Patient sex | Type of spheres | Strategy of treatment | SPECT number | Number of lesion(s) delineated | Volumes (mL) |
|---|---|---|---|---|---|---|
1 | M | Glass | HCC/Lobectomy | 1 | 1 | 30.89 |
2 | F | Glass | mCRC/Bilobar | 2 | NA | NA |
3 | F | Resin | HCC/Lobectomy | 3 | NA | NA |
4 | F | Glass | MBC/Lobectomy | 4 | NA | NA |
5 | F | Glass | mCRC/Lobectomy | 5 | NA | NA |
6 | F | Resin | mCRC/Lobectomy | 6 | NA | NA |
7 | M | Glass | HCC/Lobectomy | 7 | 1 | 54.89 |
8 | M | Glass | MBC/Lobectomy | 8 | NA | NA |
9 | F | Glass | MBC/Lobectomy | 9 | 1 | 176 |
10 | F | Glass | MBC/Lobectomy | 10 | 5 | 35.54/7.004/11.56/6.331 |
11 | F | Resin | MBC/Lobectomy | 11 | 1 | 63.74 |
12 | F | Resin | MBC/Lobectomy | 12 | NA | NA |
13 | M | Glass | HCC/Lobectomy | 13 | 3 | 436.6/44.83/432.5 (nodules) |
14 | M | Glass | MLC/Lobectomy | 14 | NA | NA |
15 | M | Glass | ICC/Lobectomy | 15 | 1 | 228.6 |
16 | M | Resin | HCC/Lobectomy | 16 | 1 | 278 |
17 | NA | NA | ||||
17 | M | Glass | ICC/Lobectomy | 18 | 1 | 223 |
19 | NA | NA | ||||
18 | F | Resin | MLC/Lobectomy | 20 | 1 | 3.444 |
19 | M | Resin | HCC/Lobectomy | 21 | 1 | 428.7 |
20 | M | Resin | HCC/Lobectomy | 22 | 2 | 105.2/23.35 |
21 | M | Glass | HCC/Lobectomy | 23 | NA | NA |
22 | F | Glass | mCRC/Lobectomy | 24 | 1 | 14.15 |
23 | M | Glass | M/Lobectomy | 25 | 1 | 1828 |
24 | F | Resin | MBC/Lobectomy | 26 | 1 | 213.9 |
25 | M | Resin | HCC/Lobectomy | 27 | 1 | 37.01 |
26 | M | Glass | HCC/Lobectomy | 28 | 2 | 12.99/225.8 |
27 | F | Glass | MPC/Lobectomy | 29 | 4 | 121.4/106.6/92.65/46.76 |
28 | F | Resin | MNT/Lobectomy | 30 | 1 | 106.1 |
29 | M | Glass | ICC/Lobectomy | 31 | 2 | 13.94/19.38 |